Yama Issa1, Marinus A Kempeneers1, Marco J Bruno2, Paul Fockens3, Jan-Werner Poley2, Usama Ahmed Ali1, Thomas L Bollen4, Olivier R Busch1, Cees H Dejong5,6, Peter van Duijvendijk7, Hendrik M van Dullemen8, Casper H van Eijck9, Harry van Goor10, Muhammed Hadithi11, Jan-Willem Haveman12, Yolande Keulemans13, Vincent B Nieuwenhuijs14, Alexander C Poen15, Erik A Rauws3, Adriaan C Tan16, Willem Thijs17, Robin Timmer18, Ben J Witteman19, Marc G Besselink1, Jeanin E van Hooft3, Hjalmar C van Santvoort20,21, Marcel G Dijkgraaf22, Marja A Boermeester1. 1. Department of Surgery, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 2. Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, Amsterdam, the Netherlands. 3. Department of Gastroenterology and Hepatology; Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. 4. Department of Radiology, St Antonius Hospital, Nieuwegein, the Netherlands. 5. Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands. 6. Department of Surgery, Universitätsklinikum Aachen, Aachen, Germany. 7. Department of Surgery, Gelre Hospital, Apeldoorn, the Netherlands. 8. Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 9. Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. 10. Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands. 11. Department of Gastroenterology and Hepatology, Maasstad Hospital, Rotterdam, the Netherlands. 12. Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 13. Department of Gastroenterology and Hepatology, Zuyderland Hospital, Sittard/Heerlen, the Netherlands. 14. Department of Surgery, Isala Hospital, Zwolle, the Netherlands. 15. Department of Gastroenterology and Hepatology, Isala Hospital, Zwolle, the Netherlands. 16. Department of Gastroenterology and Hepatology, Canisius-Wilhemina Hospital, Nijmegen, the Netherlands. 17. Department of Gastroenterology and Hepatology, Martini Hospital, Groningen, the Netherlands. 18. Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, the Netherlands. 19. Department of Gastroenterology and Hepatology, Gelderse Vallei Hospital, Ede, the Netherlands. 20. Department of Surgery, St Antonius Hospital, Nieuwegein, the Netherlands. 21. Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands. 22. Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam Public Health, Amsterdam UMC, University of Amsterdam, the Netherlands.
Abstract
Importance: For patients with painful chronic pancreatitis, surgical treatment is postponed until medical and endoscopic treatment have failed. Observational studies have suggested that earlier surgery could mitigate disease progression, providing better pain control and preserving pancreatic function. Objective: To determine whether early surgery is more effective than the endoscopy-first approach in terms of clinical outcomes. Design, Setting, and Participants: The ESCAPE trial was an unblinded, multicenter, randomized clinical superiority trial involving 30 Dutch hospitals participating in the Dutch Pancreatitis Study Group. From April 2011 until September 2016, a total of 88 patients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started using prescribed opioids for severe pain (strong opioids for ≤2 months or weak opioids for ≤6 months) were included. The 18-month follow-up period ended in March 2018. Interventions: There were 44 patients randomized to the early surgery group who underwentpancreatic drainage surgery within 6 weeks after randomization and 44 patients randomized to the endoscopy-first approach group who underwent medical treatment, endoscopy including lithotripsy if needed, and surgery if needed. Main Outcomes and Measures: The primary outcome was pain, measured on the Izbicki pain score and integrated over 18 months (range, 0-100 [increasing score indicates more pain severity]). Secondary outcomes were pain relief at the end of follow-up; number of interventions, complications, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Health Survey [SF-36]); and mortality. Results: Among 88 patients who were randomized (mean age, 52 years; 21 (24%) women), 85 (97%) completed the trial. During 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, -12 points [95% CI, -22 to -2]; P = .02). Complete or partial pain relief at end of follow-up was achieved in 23 of 40 patients (58%) in the early surgery vs 16 of 41 (39%)in the endoscopy-first approach group (P = .10). The total number of interventions was lower in the early surgery group (median, 1 vs 3; P < .001). Treatment complications (27% vs 25%), mortality (0% vs 0%), hospital admissions, pancreatic function, and quality of life were not significantly different between early surgery and the endoscopy-first approach. Conclusions and Relevance: Among patients with chronic pancreatitis, early surgery compared with an endoscopy-first approach resulted in lower pain scores when integrated over 18 months. However, further research is needed to assess persistence of differences over time and to replicate the study findings. Trial Registration: ISRCTN Identifier: ISRCTN45877994.
RCT Entities:
Importance: For patients with painful chronic pancreatitis, surgical treatment is postponed until medical and endoscopic treatment have failed. Observational studies have suggested that earlier surgery could mitigate disease progression, providing better pain control and preserving pancreatic function. Objective: To determine whether early surgery is more effective than the endoscopy-first approach in terms of clinical outcomes. Design, Setting, and Participants: The ESCAPE trial was an unblinded, multicenter, randomized clinical superiority trial involving 30 Dutch hospitals participating in the Dutch Pancreatitis Study Group. From April 2011 until September 2016, a total of 88 patients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started using prescribed opioids for severe pain (strong opioids for ≤2 months or weak opioids for ≤6 months) were included. The 18-month follow-up period ended in March 2018. Interventions: There were 44 patients randomized to the early surgery group who underwent pancreatic drainage surgery within 6 weeks after randomization and 44 patients randomized to the endoscopy-first approach group who underwent medical treatment, endoscopy including lithotripsy if needed, and surgery if needed. Main Outcomes and Measures: The primary outcome was pain, measured on the Izbicki pain score and integrated over 18 months (range, 0-100 [increasing score indicates more pain severity]). Secondary outcomes were pain relief at the end of follow-up; number of interventions, complications, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Health Survey [SF-36]); and mortality. Results: Among 88 patients who were randomized (mean age, 52 years; 21 (24%) women), 85 (97%) completed the trial. During 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, -12 points [95% CI, -22 to -2]; P = .02). Complete or partial pain relief at end of follow-up was achieved in 23 of 40 patients (58%) in the early surgery vs 16 of 41 (39%)in the endoscopy-first approach group (P = .10). The total number of interventions was lower in the early surgery group (median, 1 vs 3; P < .001). Treatment complications (27% vs 25%), mortality (0% vs 0%), hospital admissions, pancreatic function, and quality of life were not significantly different between early surgery and the endoscopy-first approach. Conclusions and Relevance: Among patients with chronic pancreatitis, early surgery compared with an endoscopy-first approach resulted in lower pain scores when integrated over 18 months. However, further research is needed to assess persistence of differences over time and to replicate the study findings. Trial Registration: ISRCTN Identifier: ISRCTN45877994.
Authors: Asbjørn M Drewes; Stefan A W Bouwense; Claudia M Campbell; Güralp O Ceyhan; Myriam Delhaye; Ihsan Ekin Demir; Pramod K Garg; Harry van Goor; Christopher Halloran; Shuiji Isaji; John P Neoptolemos; Søren S Olesen; Tonya Palermo; Pankaj Jay Pasricha; Andrea Sheel; Tooru Shimosegawa; Eva Szigethy; David C Whitcomb; Dhiraj Yadav Journal: Pancreatology Date: 2017-07-13 Impact factor: 3.996
Authors: J Matthias Löhr; Enrique Dominguez-Munoz; Jonas Rosendahl; Marc Besselink; Julia Mayerle; Markus M Lerch; Stephan Haas; Fatih Akisik; Nikolaos Kartalis; Julio Iglesias-Garcia; Jutta Keller; Marja Boermeester; Jens Werner; Jean-Marc Dumonceau; Paul Fockens; Asbjorn Drewes; Gürlap Ceyhan; Björn Lindkvist; Joost Drenth; Nils Ewald; Philip Hardt; Enrique de Madaria; Heiko Witt; Alexander Schneider; Riccardo Manfredi; Frøkjer J Brøndum; Sasa Rudolf; Thomas Bollen; Marco Bruno Journal: United European Gastroenterol J Date: 2017-01-16 Impact factor: 4.623
Authors: Timothy B Gardner; Abigail T Kennedy; Andres Gelrud; Peter A Banks; Santhi Swaroop Vege; Stuart R Gordon; Brian E Lacy Journal: Pancreas Date: 2010-05 Impact factor: 3.327
Authors: B Lamme; M A Boermeester; I H Straatsburg; J M van Buijtenen; D Boerma; G J A Offerhaus; D J Gouma; T M van Gulik Journal: Br J Surg Date: 2007-07 Impact factor: 6.939
Authors: Usama Ahmed Ali; Vincent B Nieuwenhuijs; Casper H van Eijck; Hein G Gooszen; Ronald M van Dam; Olivier R Busch; Marcel G W Dijkgraaf; Femke A Mauritz; Sjoerd Jens; Jay Mast; Harry van Goor; Marja A Boermeester Journal: Arch Surg Date: 2012-10
Authors: Usama Ahmed Ali; Yama Issa; Marco J Bruno; Harry van Goor; Hjalmar van Santvoort; Olivier R C Busch; Cornelis H C Dejong; Vincent B Nieuwenhuijs; Casper H van Eijck; Hendrik M van Dullemen; Paul Fockens; Peter D Siersema; Dirk J Gouma; Jeanin E van Hooft; Yolande Keulemans; Jan W Poley; Robin Timmer; Marc G Besselink; Frank P Vleggaar; Oliver H Wilder-Smith; Hein G Gooszen; Marcel G W Dijkgraaf; Marja A Boermeester Journal: BMC Gastroenterol Date: 2013-03-18 Impact factor: 3.067
Authors: Furqan A Bhullar; Mahya Faghih; Venkata S Akshintala; Ahmed I Ahmed; Katie Lobner; Elham Afghani; Anna E Phillips; Phil A Hart; Mitchell L Ramsey; Benjamin L Bick; Louise Kuhlmann; Asbjørn M Drewes; Dhiraj Yadav; Søren S Olesen; Vikesh K Singh Journal: Pancreatology Date: 2021-11-18 Impact factor: 3.996
Authors: Emily R Perito; John F Pohl; Caitlin Bakker; Matthew A Armfield; Bradley Barth; Addison Cuneo; Maria Mascarenhas; Megha Mehta; Sarah Jane Schwarzenberg Journal: Pancreas Date: 2022-02-01 Impact factor: 3.327
Authors: Isaac L Jaben; Gregory A Coté; Erin Forster; Robert A Moran; Kent A Broussard; Norman Scott; Peter B Cotton; Thomas Keane; B Joseph Elmunzer Journal: Clin Gastroenterol Hepatol Date: 2020-07-23 Impact factor: 11.382
Authors: Dhiraj Yadav; Tonya M Palermo; Anna E Phillips; Melena D Bellin; Darwin L Conwell Journal: Curr Opin Gastroenterol Date: 2021-09-01 Impact factor: 2.741
Authors: Antonie Willner; Andreas Bogner; Benjamin Müssle; Christian Teske; Sebastian Hempel; Christoph Kahlert; Marius Distler; Jürgen Weitz; Thilo Welsch Journal: Medicine (Baltimore) Date: 2020-10-30 Impact factor: 1.817
Authors: Tonya M Palermo; Emily F Law; Mark D Topazian; Katherine Slack; Blake F Dear; Yeon Joo Ko; Santhi Swaroop Vege; Evan Fogel; Guru Trikudanathan; Dana K Andersen; Darwin L Conwell; Dhiraj Yadav Journal: Clin Transl Gastroenterol Date: 2021-06-18 Impact factor: 4.488